KEVIN JOHNSON: Open Payments
NPI 1396155511 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 32 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $261 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $221 |
| Teva Pharmaceuticals USA, Inc. | 9 | $167 |
| Alkermes, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Corium, LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Braeburn Inc. | 1 | $16 |
Products named: COBENFY, AUSTEDO XR, INGREZZA, Azstarys, LYBALVI, UZEDY, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across NY — which companies pay providers there.
